RNU6-346P

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, RNU6-346P RNA is linked to patient survival in 18 of 34 cancer types, making it the most broadly survival-associated RNU6-346P data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RNU6-346P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-346P expression acts as an unfavorable survival marker, although some lineages such as BRCA and THCA show a favorable association.

HNSC, CHOL, and BRCA are the cancer types where RNU6-346P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
HNSCOSTertileAll0.5180.739.00239view →
CHOLOSTertileII,III,IV0.0190.675<.00136view →
BRCADFSTertileAll0.9810.941.00336view →
KIRCDFSTertileII,III,IV0.4660.683.04024view →
READDFSTertileIV0.2170.657.00618view →
UCECDFSTertileIV0.2180.601.01518view →
THCADFSTertileAll0.9830.923.01115view →
CESCOSTertileII,III,IV0.9490.719.03112view →
ESCADFSQuartileIV0.8260.309.04012view →
SKCMDFSQuartileIV0.0400.733.00811view →
UVMDFSQuartileII,III,IV0.5600.790.02111view →
SARCDFSQuartileAll0.7390.576.00211view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 18 lineages.

RNU6-346P–HNSC (OS)

Kaplan–Meier survival curve for RNU6-346P RNA-high vs -low samples in HNSC.

Open the HNSC breakdown →

Exploration